Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?

被引：0
|
作者：
Davis, BJ [1 ]
Forbes, JM [1 ]
Jerums, G [1 ]
Cooper, ME [1 ]
Allen, TJ [1 ]
机构：
[1] Univ Melbourne, Dept Med, Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia
来源：
JOURNAL OF HYPERTENSION | 2002年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P212
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice
    Tamarat, R
    Silvestre, JS
    Huijberts, M
    Benessiano, J
    Ebrahimian, TG
    Duriez, M
    Wautier, MP
    Wautier, JL
    Lévy, BI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) : 8555 - 8560
  • [2] Glycation and advanced glycation end-product formation with icodextrin and dextrose
    Dawnay, ABSJ
    Millar, DJ
    PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 (01): : 52 - 58
  • [3] An advanced glycation end-product receptor polymorphism postpones the development of diabetic nephropathy in Type 1 diabetic patients
    Tarnow, L
    Hovind, P
    Hansen, BV
    Christensen, PK
    Rossing, K
    Jacobsen, PK
    Cambien, F
    Parving, HH
    DIABETOLOGIA, 2002, 45 : A357 - A358
  • [4] Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy
    Sourris, Karly C.
    Harcourt, Brooke E.
    Penfold, Sally A.
    Yap, Felicia Y. T.
    Morley, Amy L.
    Morgan, Philip E.
    Davies, Michael J.
    Baker, Scott T.
    Jerums, George
    Forbes, Josephine M.
    EXPERIMENTAL DIABETES RESEARCH, 2010,
  • [5] An advanced glycation end-product receptor polymorphism postpones the development of diabetic nephropathy in type I diabetic patients.
    Tarnow, L
    Hovind, P
    Hansen, BV
    Christensen, PK
    Rossing, K
    Jacobsen, P
    Cambien, F
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 246A - 246A
  • [6] Renoprotection of anti-hypertensive agents is associated with inhibition of advanced glycation end product (AGE) formation.
    Miyata, T
    Nangaku, M
    Ishikawa, N
    Inagi, R
    Ueda, Y
    de Strihou, CV
    Kurokawa, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 396A - 396A
  • [7] GLUCOSE, GLYCATED HAEMOGLOBINAND ADVANCED GLYCATION END-PRODUCT IN TUNISIAN DIABETIC PATIENTS
    Soualhia, A.
    Chahed, H.
    Daboubi, R.
    Ben Iimam, H.
    Ferchichi, S.
    Bousrih, H.
    Chaieb, M.
    Chaieb, L.
    Maatoug, F.
    Miled, A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S369 - S369
  • [8] Gelatin as a convenient surrogate protein to model the in vitro effects of advanced glycation end-product formation
    Pringle, Nadine A.
    van de Venter, Maryna
    Koekemoer, Trevor C.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (11) : 1309 - 1311
  • [9] Mechanisms for development of diabetic nephropathy -Degradation of advanced glycation end-product - aggregated protein in mesangial cells of glomeruli-
    Nagamatsu, Tadashi
    Toda, Takahiro
    Yamamura, Shinya
    Morishita, Takuya
    Hirasawa, Yasushi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 92P - 92P
  • [10] Inhibition of advanced glycation end-product formation on eye lens protein by rutin
    Muthenna, P.
    Akileshwari, C.
    Saraswat, Megha
    Reddy, G. Bhanuprakash
    BRITISH JOURNAL OF NUTRITION, 2012, 107 (07) : 941 - 949
12345